Casteels KM - Search Results

1

Streptococcal wall component OK432 restores sensitivity of non-obese diabetic (NOD) thymocytes to apoptotic signals.

Decallonne B, Overbergh L, Casteels KM, Gysemans C, Bouillon R, Mathieu C. Decallonne B, et al. Among authors: casteels km. Diabetologia. 2000 Oct;43(10):1302-8. doi: 10.1007/s001250051526. Diabetologia. 2000. PMID: 11079749

2

PERK recruits E-Syt1 at ER-mitochondria contacts for mitochondrial lipid transport and respiration.

Sassano ML, van Vliet AR, Vervoort E, Van Eygen S, Van den Haute C, Pavie B, Roels J, Swinnen JV, Spinazzi M, Moens L, Casteels K, Meyts I, Pinton P, Marchi S, Rochin L, Giordano F, Felipe-Abrio B, Agostinis P. Sassano ML, et al. J Cell Biol. 2023 Mar 6;222(3):e202206008. doi: 10.1083/jcb.202206008. Epub 2023 Feb 23. J Cell Biol. 2023. PMID: 36821088 Free PMC article.

3

Immunomodulatory effects of 1,25-dihydroxyvitamin D3.

Casteels K, Bouillon R, Waer M, Mathieu C. Casteels K, et al. Curr Opin Nephrol Hypertens. 1995 Jul;4(4):313-8. doi: 10.1097/00041552-199507000-00005. Curr Opin Nephrol Hypertens. 1995. PMID: 7552096 Review.

4

Paracrine role for calcitriol in the immune system and skin creates new therapeutic possibilities for vitamin D analogs.

Bouillon R, Garmyn M, Verstuyf A, Segaert S, Casteels K, Mathieu C. Bouillon R, et al. Eur J Endocrinol. 1995 Jul;133(1):7-16. doi: 10.1530/eje.0.1330007. Eur J Endocrinol. 1995. PMID: 7627339 Review. No abstract available.

5

Prevention of type I diabetes in NOD mice by nonhypercalcemic doses of a new structural analog of 1,25-dihydroxyvitamin D3, KH1060.

Mathieu C, Waer M, Casteels K, Laureys J, Bouillon R. Mathieu C, et al. Endocrinology. 1995 Mar;136(3):866-72. doi: 10.1210/endo.136.3.7867594. Endocrinology. 1995. PMID: 7867594

6

Prevention of type I diabetes by late intervention with nonhypercalcemic analogues of vitamin D3 in combination with cyclosporin A.

Casteels K, Waer M, Bouillon R, Allewaert K, Laureys J, Mathieu C. Casteels K, et al. Transplant Proc. 1996 Dec;28(6):3095. Transplant Proc. 1996. PMID: 8962198 No abstract available.

7

Protection against autoimmune diabetes in mixed bone marrow chimeras: mechanisms involved.

Mathieu C, Casteels K, Bouillon R, Waer M. Mathieu C, et al. J Immunol. 1997 Feb 1;158(3):1453-7. J Immunol. 1997. PMID: 9013991

8

Prevention of type I diabetes in nonobese diabetic mice by late intervention with nonhypercalcemic analogs of 1,25-dihydroxyvitamin D3 in combination with a short induction course of cyclosporin A.

Casteels KM, Mathieu C, Waer M, Valckx D, Overbergh L, Laureys JM, Bouillon R. Casteels KM, et al. Endocrinology. 1998 Jan;139(1):95-102. doi: 10.1210/endo.139.1.5641. Endocrinology. 1998. PMID: 9421403

9

Prevention of diabetes recurrence after syngeneic islet transplantation in NOD mice by analogues of 1,25(OH)2D3 in combination with cyclosporin A: mechanism of action involves an immune shift from Th1 to Th2.

Mathieu C, Casteels K, Waer M, Laureys J, Valckx D, Bouillon R. Mathieu C, et al. Transplant Proc. 1998 Mar;30(2):541. doi: 10.1016/s0041-1345(97)01398-5. Transplant Proc. 1998. PMID: 9532170 No abstract available.

10

Prevention of autoimmune destruction of syngeneic islet grafts in spontaneously diabetic nonobese diabetic mice by a combination of a vitamin D3 analog and cyclosporine.

Casteels K, Waer M, Laureys J, Valckx D, Depovere J, Bouillon R, Mathieu C. Casteels K, et al. Transplantation. 1998 May 15;65(9):1225-32. doi: 10.1097/00007890-199805150-00014. Transplantation. 1998. PMID: 9603172

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

88 results

Search Page

Filters